Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant in patients with ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Plasma Cell Neoplasms

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: TERMINATED